Prevention of REnal and Vascular ENd-stage Disease

Overview

Acronym
PREVEND
Investigators
  • Dr. Hans Hillege

    University of Groningen

Contacts
  • Dr. Hans Hillege

    University of Groningen

General Design

Study design
Cohort
Start - End Year
1997 -
Recruitment Target
  • Individuals
Number of Participants
8,592
Number of Participants with Biological Samples
8,592
Supplementary Information

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Marker Paper

Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, De Zeeuw D, De Jong PE. J Am Soc Nephrol. 2000 Oct;11(10):1882-8

PUBMED 11004219

Timeline

Population

PREVEND cohort

Selection Criteria

Minimum age
18
Maximum age
75
Countries
  • Netherlands
Ethnic Origin
  • Caucasian

Sources of Recruitment

General Population
  • Volunteer enrolment

Sample Size

Number of Participants
8,592
Number of Participants with Biological Samples
8,592

Data Collection Events

# Name Description Start End
0 NC1 1997 1998
1 Second screening 2001 2003
2 Third screening 2003 2006
3 Fourth Screening 2009 2012

Participating Studies

Acronym Name Study design Countries

Harmonization Initiatives Included

Acronym Name

Networks

Acronym Name Harmonization Initiatives Individual Studies

Datasets

Name Type Data Collection Events Variables
Last Update: 2021-04-12 16:05